Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses

Journal of Hypertension

Volumn 34, Issue 1, 2016, Pages 97-108

  Mian, Muhammad Oneeb Rehman ^a   Barhoumi, Tlili ^a   Briet, Marie ^a,c   Paradis, Pierre ^a   Schiffrin, Ernesto L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

adaptive immunity; hypertension; innate immunity; oxidative stress

Indexed keywords

ANGIOTENSIN II; FIBRONECTIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; REACTIVE OXYGEN METABOLITE; CCL2 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; RAG-1 PROTEIN;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HYPERTENSION; IMMUNE DEFICIENCY; INNATE IMMUNITY; KIDNEY CORTEX; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MESENTERIC ARTERY; MICROVESSEL INJURY; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAG1-/- MOUSE; REGULATORY T LYMPHOCYTE; WILD TYPE; ANIMAL; ARTERIAL STIFFNESS; BLOOD PRESSURE; CD4 LYMPHOCYTE COUNT; CHEMISTRY; DEFICIENCY; DRUG EFFECTS; ENDOTHELIUM; GENETICS; IMMUNOLOGY; METABOLISM; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR REMODELING;

ADIPOSE TISSUE; ADOPTIVE TRANSFER; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CD4 LYMPHOCYTE COUNT; CHEMOKINE CCL2; ENDOTHELIUM; FORKHEAD TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEINS; HYPERTENSION; IMMUNITY, INNATE; KIDNEY CORTEX; MACROPHAGES; MALE; MESENTERIC ARTERIES; MICE; MICE, KNOCKOUT; MICROVESSELS; MONOCYTES; OXIDATIVE STRESS; T-LYMPHOCYTES, REGULATORY; VASCULAR REMODELING; VASCULAR STIFFNESS;

EID: 84950133270     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000761     Document Type: Article

References (36)

1. Mian MO, Paradis P, Schiffrin EL. Innate immunity in hypertension. Curr Hypertens Rep 2014; 16:413.
2. Idris-Khodja N, Mian MO, Paradis P, Schiffrin EL. Dual opposing roles of adaptive immunity in hypertension. Eur Heart J 2014; 35:1238-1244.
3. De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 2005; 25:2106-2113.
4. Wenzel P, Knorr M, Kossmann S, Stratmann J, Hausding M, Schuhmacher S, et al. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 2011; 124:1370-1381.
5. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204:2449-2460.
6. Kassan M, Wecker A, Kadowitz P, Trebak M, Matrougui K. CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension. J Hypertens 2013; 31:1939-1943.
7. Valencia X, Lipsky PE. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Prac Rheumatol 2007; 3:619-626.
8. Taleb S, Tedgui A, Mallat Z. Regulatory T-cell immunity and its relevance to atherosclerosis. J Intern Med 2008; 263:489-499.
9. Schiffrin EL. Immune mechanisms in hypertension and vascular injury. Clin Sci 2014; 126:267-274.
10. Viel EC, Lemarie CA, Benkirane K, Paradis P, Schiffrin EL. Immune regulation and vascular inflammation in genetic hypertension. Am J Physiol Heart Circulatory Physiol 2010; 298:H938-H944.
11. Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, et al. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011; 57:469-476.
12. Matrougui K, Abd Elmageed Z, Kassan M, Choi S, Nair D, Gonzalez-Villalobos RA, et al. Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol 2011; 178:434-441.
13. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A, et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 2012; 59:324-330.
14. Leibovitz E, Ebrahimian T, Paradis P, Schiffrin EL. Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction. J Hypertens 2009; 27:2192-2200.
15. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest 2008; 118:3522-3530.
16. Wu J, Thabet SR, Kirabo A, Trott DW, Saleh MA, Xiao L, et al. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res 2014; 114:616-625.
17. Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 2009; 20:1744-1753.
18. Yang F, Dong A, Mueller P, Caicedo J, Sutton AM, Odetunde J, et al. Coronary artery remodeling in a model of left ventricular pressure overload is influenced by platelets and inflammatory cells. PloS One 2012; 7:e40196.
19. Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1beta release through pyrophosphates. EMBO J 2009; 28:2114-2127.
20. Rodriguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chavez M, Herrera-Acosta J, et al. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002; 282:F191-F201.
21. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, et al. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regulat Integr Compar Physiol 2009; 296:R208-R216.
22. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 2004; 5:818-827.
23. Nataraj C, Oliverio MI, Mannon RB, Mannon PJ, Audoly LP, Amuchastegui CS, et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Investig 1999; 104:1693-1701.
24. Yanagitani Y, Rakugi H, Okamura A, Moriguchi K, Takiuchi S, Ohishi M, et al. Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension 1999; 33 (1 Pt 2):335-339.
25. Weirather J, Hofmann UD, Beyersdorf N, Ramos GC, Vogel B, Frey A, et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res 2014; 115:55-67.
26. Kassan M, Galan M, Partyka M, Trebak M, Matrougui K. Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscl Thromb Vasc Biol 2011; 31:2534-2542.
27. Curfs JH, Meis JF, Hoogkamp-Korstanje JA. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev 1997; 10:742-780.
28. Brands MW, Banes-Berceli AK, Inscho EW, Al-Azawi H, Allen AJ, Labazi H. Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension 2010; 56:879-884.
29. Han YL, Li YL, Jia LX, Cheng JZ, Qi YF, Zhang HJ, et al. Reciprocal interaction between macrophages and T cells stimulates IFN-gamma and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis. PloS One 2012; 7:e35506.
30. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010; 55:500-507.
31. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008; 51:1345-1351.
32. Zhang W, Wang W, Yu H, Zhang Y, Dai Y, Ning C, et al. Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension 2012; 59:136-144.
33. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10:170-181.
34. Guyton AC. Renal function curve: a key to understanding the pathogenesis of hypertension. Hypertension 1987; 10:1-6.
35. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Investig 2005; 115:1092-1099.
36. Saleh MA, McMaster WG, Wu J, Norlander AE, Funt SA, Thabet SR, et al. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Investig 2015; 125:1189-1202.